Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2400206	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2024-09-12					view
JYSB2400207	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2024-09-12					view
JYSB2400191	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2024-08-26					view
JYSB2400190	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2024-08-26					view
JYSZ2400034	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	License Renew	2024-06-21					view
JYSZ2400033	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	License Renew	2024-06-21					view
JYSB2300156	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2023-09-12					view
JYSB2300155	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2023-09-12					view
JTS2200110	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Disposable Import Drug Application	2022-12-31					view
JYSB2200017	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2022-02-11					view
JYSB2200018	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2022-02-11					view
JYSB2000654	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-12-25	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2021-01-06	view
JYSB2000653	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-12-25	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2021-01-06	view
JYSB2000426	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-09-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-11	view
JYSB2000425	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-09-01	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-11	view
JYSB2000332	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-06-30	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-07-01	view
JYSB2000331	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-06-30	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-07-01	view
JXSS2000016	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Import Drug Application	2020-05-27	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2020-05-26	view
JXSS2000017	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Import Drug Application	2020-05-27	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2020-05-26	view
JYSB2000157	注射用恩美曲妥珠单抗	trastuzumab emtansine	Lyophilized	Biological Products	Supplementary Application	2020-05-16	上海罗氏制药有限公司	Shanghai Roche Pharmaceutical Co Ltd	In Review	2020-05-15	view